Posted inNews Prevention Research Sexual Health
UK DoxyPEP study recruiting participants
A new study in the UK investigating the effect of DoxyPEP on the gut microbiome…
Posted inUncategorized
Scotland leads the UK in approving injectable HIV PrEP
The Scottish Medicines Consortium (SMC) has approved CAB-LA, an injection taken every two months, for…
Posted inCampaigning News Testing
Prime Minister takes a HIV test to kick off HIV Testing Week in England
Sir Keir Starmer, the Prime Minister of the United Kingdom, has become the first G20…
Posted inNews Sexual Health
Rising syphilis rates in West Midlands cause concern
New data from the UK Health Security Agency, published last Friday, shows a steep increase…
Gilead to support generic lenacapavir in low-income nations
Earlier this month, Gilead Sciences announced that it had signed non-exclusive, royalty-free voluntary licensing agreements…
Posted inCampaigning International News Prevention
Activists demand global access to HIV prevention drug
HIV and sexual health activists protested today at Gilead Sciences' London Office demanding the company…
Posted inNews PrEP Prevention Research
Twice-yearly lenacapavir 89% more effective than Truvada
New data from the PURPOSE 2 study shows that twice-yearly lenacapavir is 89% more effective…
Posted inInternational News PrEP Prevention
Concern as PrEP supplies run low in Australia
Australian sexual health and HIV organisations are sending out reminders for PrEP users to "plan…
Posted inHealthcare International News PrEP Prevention
PrEP approved to prevent HIV in Japan
Japan has approved the use of Truvada (TDF/FTC), sold by Gilead Sciences under the brand name Truvada, as PrEP for the prevention of HIV in the country.
Posted inCommunity News News Stigma Support
Birmingham HIV peer support services joins Saving Lives family
Birmingham Positive Peers, the only organisation in the West Midlands to offer peer support services…